David L. Lacey Arcus Biosciences, Inc. (RCUS) insider trading activity

RCUS Quotes by TradingView

David L. Lacey is Director of Arcus Biosciences, Inc.. Currently has a direct ownership of 70,952 shares of RCUS, which is worth approximately $700,296. The most recent transaction as insider was on Jun 10, 2025, when has been sold 13,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 71K
23.07% 3M change
23.07% 12M change
Total Value Held $700,296

David L. Lacey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2025
BUY
Grant, award, or other acquisition
-
13,300 Added 15.79%
70,952 Common Stock
Jun 06 2024
BUY
Grant, award, or other acquisition
-
8,400 Added 12.72%
57,652 Common Stock
Jun 15 2023
BUY
Grant, award, or other acquisition
-
6,800 Added 12.13%
49,252 Common Stock
Jun 14 2022
BUY
Grant, award, or other acquisition
-
4,100 Added 8.81%
42,452 Common Stock
Jun 03 2021
BUY
Grant, award, or other acquisition
-
3,000 Added 7.25%
38,352 Common Stock

Also insider at

NRIX
Nurix Therapeutics, Inc. Healthcare
Director
BCEL
Atreca, Inc. Healthcare
Director
DLL

David L. Lacey

Director
Hayward, CA

Track Institutional and Insider Activities on RCUS

Follow Arcus Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCUS shares.

Notify only if

Insider Trading

Get notified when an Arcus Biosciences, Inc. insider buys or sells RCUS shares.

Notify only if

News

Receive news related to Arcus Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RCUS